Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders.
Looking for a particular Versantis employee's phone or email?
The Versantis annual revenue was $3 million in 2026.
2 people are employed at Versantis.
The NAICS codes for Versantis are [32, 325, 3254, 32541].
The SIC codes for Versantis are [28, 283].